Marko Poglitsch

5.3k total citations · 2 hit papers
93 papers, 3.8k citations indexed

About

Marko Poglitsch is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Marko Poglitsch has authored 93 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Cardiology and Cardiovascular Medicine, 47 papers in Endocrinology, Diabetes and Metabolism and 18 papers in Molecular Biology. Recurrent topics in Marko Poglitsch's work include Hormonal Regulation and Hypertension (45 papers), Renin-Angiotensin System Studies (40 papers) and Blood Pressure and Hypertension Studies (12 papers). Marko Poglitsch is often cited by papers focused on Hormonal Regulation and Hypertension (45 papers), Renin-Angiotensin System Studies (40 papers) and Blood Pressure and Hypertension Studies (12 papers). Marko Poglitsch collaborates with scholars based in Austria, United States and Australia. Marko Poglitsch's co-authors include Marcus D. Säemann, Walter H. Hörl, Thomas Weichhart, Maximilian Zeyda, Thomas M. Stulnig, Oliver Domenig, Markus Hengstschläger, Mathias Müller, Margit Rosner and Josef Penninger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Marko Poglitsch

88 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response

2008 655 citations Thomas Weichhart, Marko Poglitsch et al. profile →
Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure

2019 248 citations A.H. Jan Danser, Marko Poglitsch et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marko Poglitsch Austria	28	1.2k	1.0k	801	749	711	93	3.8k
Michael Gosselin United States	6	1.2k 1.1×	681 0.7×	849 1.1×	563 0.8×	902 1.3×	9	3.2k
Raju Jeyaseelan United States	12	1.6k 1.3×	946 0.9×	772 1.0×	256 0.3×	891 1.3×	16	3.2k
Renu Sarao Canada	17	1.4k 1.2×	2.0k 1.9×	774 1.0×	726 1.0×	1.8k 2.5×	20	5.8k
Kevin Godbout United States	6	1.9k 1.6×	809 0.8×	1.2k 1.5×	244 0.3×	1.1k 1.6×	7	3.6k
Mei Xue China	32	573 0.5×	1.4k 1.4×	541 0.7×	300 0.4×	259 0.4×	116	3.4k
Mohamed Abu‐Farha Kuwait	33	749 0.6×	1.3k 1.3×	641 0.8×	207 0.3×	555 0.8×	129	3.4k
Satoshi Fujii Japan	35	624 0.5×	1.9k 1.8×	218 0.3×	673 0.9×	403 0.6×	149	4.5k
Keiji Kuba Japan	29	744 0.6×	1.3k 1.2×	360 0.4×	487 0.7×	2.3k 3.2×	59	5.2k
Carol Ho-Yan Fong Hong Kong	24	488 0.4×	1.2k 1.2×	421 0.5×	377 0.5×	573 0.8×	64	3.1k
Yoshinari Uehara Japan	32	756 0.7×	1.0k 1.0×	739 0.9×	303 0.4×	164 0.2×	173	3.4k

Countries citing papers authored by Marko Poglitsch

Since Specialization

Citations

This map shows the geographic impact of Marko Poglitsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Poglitsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Poglitsch more than expected).

Fields of papers citing papers by Marko Poglitsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko Poglitsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Poglitsch. The network helps show where Marko Poglitsch may publish in the future.

Co-authorship network of co-authors of Marko Poglitsch

This figure shows the co-authorship network connecting the top 25 collaborators of Marko Poglitsch. A scholar is included among the top collaborators of Marko Poglitsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko Poglitsch. Marko Poglitsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shoemaker, Robin, Marko Poglitsch, Hong Huang, et al.. (2023). Association of Elevated Serum Aldosterone Concentrations in Pregnancy with Hypertension. Biomedicines. 11(11). 2954–2954. 3 indexed citations

Tretter, Verena, Benjamin Vigl, Marko Poglitsch, et al.. (2023). Combined angiotensin-converting enzyme and aminopeptidase inhibition for treatment of experimental ventilator-induced lung injury in mice. Frontiers in Physiology. 14. 1109452–1109452.

Hartl, Lukas, Oliver Domenig, Benedikt Simbrunner, et al.. (2023). The systemic and hepatic alternative renin–angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation. Scientific Reports. 13(1). 953–953. 14 indexed citations

Kovarík, J, Christopher C. Kaltenecker, Oliver Domenig, et al.. (2021). Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study. Diabetes Therapy. 12(9). 2485–2498. 7 indexed citations

Rooyen, Johannes M. Van, Marko Poglitsch, Catharina M. C. Mels, et al.. (2021). Aldosterone and angiotensin II profiles in young black and white women using different hormonal contraceptives: the African-PREDICT study. Journal of Human Hypertension. 36(8). 711–717. 3 indexed citations

Bovée, Dominique M., Liwei Ren, Estrellita Uijl, et al.. (2021). Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease. Hypertension. 77(5). 1600–1612. 22 indexed citations

Pávó, Noémi, Suriya Prausmüller, Georg Spinka, et al.. (2021). Myocardial Angiotensin Metabolism in End-Stage Heart Failure. Journal of the American College of Cardiology. 77(14). 1731–1743. 13 indexed citations

Taschler, Ulrike, Oliver Domenig, Marko Poglitsch, et al.. (2020). Dipeptidyl peptidase 3 modulates the renin–angiotensin system in mice. Journal of Biological Chemistry. 295(40). 13711–13723. 40 indexed citations

Kaltenecker, Christopher C., Oliver Domenig, Chantal Kopecky, et al.. (2020). Critical Role of Neprilysin in Kidney Angiotensin Metabolism. Circulation Research. 127(5). 593–606. 25 indexed citations

10.

Gafane‐Matemane, Lebo F., et al.. (2020). Associations of central and peripheral blood pressure with the renin-angiotensin-aldosterone system in healthy young adults: the African-PREDICT study. Hypertension Research. 44(4). 435–445. 7 indexed citations

11.

Uijl, Estrellita, Katrina M. Mirabito Colafella, Yuan Sun, et al.. (2019). Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver Angiotensinogen. Hypertension. 73(6). 1249–1257. 88 indexed citations

12.

Dzib, José Felipe Golib, Amanda J. Rickard, Fábio L. Fernandes‐Rosa, et al.. (2019). Retinoic acid receptor α as a novel contributor to adrenal cortex structure and function through interactions with Wnt and Vegfa signalling. Scientific Reports. 9(1). 9 indexed citations

13.

Kovarík, J, Christopher C. Kaltenecker, Chantal Kopecky, et al.. (2019). Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation. Scientific Reports. 9(1). 9762–9762. 12 indexed citations

14.

Cohn, Dianne, et al.. (2018). Losartan prevents the elevation of blood pressure in adipose-PRR deficient female mice while elevated circulating sPRR activates the renin-angiotensin system. American Journal of Physiology-Heart and Circulatory Physiology. 316(3). H506–H515. 23 indexed citations

15.

Caroccia, Brasilina, Mirko Menegolo, Teresa Maria Seccia, et al.. (2017). Urotensin II Exerts Pressor Effects By Stimulating Renin And Aldosterone Synthase Gene Expression. Scientific Reports. 7(1). 13876–13876. 5 indexed citations

16.

Domenig, Oliver, Arndt Manzel, Nadja Grobe, et al.. (2016). Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney. Scientific Reports. 6(1). 33678–33678. 70 indexed citations

17.

Veghel, Richard van, René de Vries, Ingrid M. Garrelds, et al.. (2015). Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats. Kidney International. 88(1). 109–120. 39 indexed citations

18.

Manzel, Arndt, Oliver Domenig, Ágnes Zsófia Kovács, et al.. (2014). Angiotensin IV is Induced in Experimental Autoimmune Encephalomyelitis but Fails to Influence the Disease. Journal of Neuroimmune Pharmacology. 9(4). 533–543. 2 indexed citations

19.

Poglitsch, Marko, Karl Katholnig, Marcus D. Säemann, & Thomas Weichhart. (2011). Rapid isolation of nuclei from living immune cells by a single centrifugation through a multifunctional lysis gradient. Journal of Immunological Methods. 373(1-2). 167–173. 11 indexed citations

20.

Säemann, Marcus D., Marko Poglitsch, Chantal Kopecky, et al.. (2010). The versatility of HDL: a crucial anti‐inflammatory regulator. European Journal of Clinical Investigation. 40(12). 1131–1143. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact